COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1422: Articles 14211-14220  | Next

Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication
Romero, M. E., Long, C., La Rocco, D., Keerthi, A. M., Xu, D., Yu, J.
10.1101/2021.07.12.452099 — Posted: 2021-07-13 Discussion: Onsite
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
Grandi, A., Tomasi, M., Accordini, S., Bertelli, C., Vanzo, T., Gagliardi, A., Caproni, E., Tamburini, S., Fantappie, L., Di Lascio, G., Bisoffi, Z., Piubelli, C., Valenti, M. T., Dalle Carbonare, L., Zipeto, D., Rava, M., Fumagalli, V., Di Lucia, P., Marotta, D., Sala, E., Iannacone, M., Cherepanov, P., Bolognesi, M., Pizzato, M., Grandi, G.
10.1101/2021.07.12.452027 — Posted: 2021-07-13
TNF-α levels in respiratory samples are associated with SARS-CoV-2 infection.
Pereson, M. J., Badano, M. N., Aloisi, N., Chuit, R., Braco, M. M., Bare, P.
10.1101/2021.07.12.452071 — Posted: 2021-07-13
Indications that Stockholm has reached herd immunity, given limited restrictions, against several variants of SARS-CoV-2
Carlsson, M., Soderberg-Naucler, C.
10.1101/2021.07.07.21260167 — Posted: 2021-07-13 Discussion: Onsite
Transmission of SARS-CoV-2 into and within immigrant households. Nation-wide registry-study from Norway
Methi, F., Hart, R. K., Godoy, A. A., Jorgensen, S. B., Kacelnik, O., Telle, K. E.
10.1101/2021.07.09.21260253 — Posted: 2021-07-13
Mode of Presentation and Outcomes of COVID-19 Cases in a Tertiary Hospital in Nigeria
Raji, Y. E., Waziri, B., Hussaini, S. A., Ja'agi, A. I., Alhaji, U. I., Aliyu, A. M., Muhammad, A., Garba, A. S.
10.1101/2021.07.06.21260084 — Posted: 2021-07-13
Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine
Larsen, V. B., Grosland, M., Telle, K. E., Magnusson, K.
10.1101/2021.07.09.21260250 — Posted: 2021-07-13
Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Rose, R., Neumann, F., Grobe, O., Lorentz, T., Fickenscher, H., Krumbholz, A.
10.1101/2021.07.09.21260251 — Posted: 2021-07-13
Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19
Banday, A. R., Stanifer, M. L., Florez-Vargas, O., Onabajo, O. O., Zahoor, M. A., Papenberg, B. W., Ring, T. J., Lee, C.-H., Andreakos, E., Arons, E., Barsh, G., Biesecker, L. G., Boyle, D. L., Burnett-Hartman, A., Carrington, M., Chang, E., Choe, P. G., Chrisholm, R. L., Dalgard, C., Edberg, J., Erdmann, N., Feigelson, H. S., Firestein, G. S., Gehring, A. J., Ho, M., Holland, S., Hutchinson, A. A., Im, H., Ison, M. G., Kim, H. B., Kreitman, R. J., Korf, B. R., Mirabello, L., Pacheco, J. A., Peluso, M. J., Rader, D. J., Redden, D. T., Ritchie, M. D., Rosenbloom, B., Sant Anna, H. P., Savage, S., Siouti, E., Triantafyllia, V., Vargas, J. M., Verma, A., Vij, V., Wesemann, D. R., Yeager, M., Yu, X., Zhang, Y., Boulant, S., Chanock, S. J., Feld, J. J., Prokunina-Olsson, L.
10.1101/2021.07.09.21260221 — Posted: 2021-07-13
COVID-19 vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination among primary school teachers in Poland
Malesza, M., Sobolewska, K.
10.1101/2021.07.11.21260317 — Posted: 2021-07-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).